TP53 and neoplasm: Senescence growth arrest usually depends on the activation of the CDK inhibitors (p21CIP1 and p16INK4A) [30, 31], components of the tumor-suppressor pathways governed by p53 and pRb, and is generally associated with a G0/G1 cell cycle arrest.